AcouSort and Pharmacolog sign letter of intent to investigate integration of AcouSort’s blood separation technology
AcouSort AB and Uppsala-based Pharmacolog AB has signed a letter of intent concerning a long-term collaboration focused on investigating the potential of integrating AcouSort’s technology in Pharmacolog’s products. The aim is that the collaboration will result in the development of a novel product for determination of antibiotic concentration in blood from critically ill patients.During early spring, AcouSort has performed proof-of-principle studies together with Pharmacolog. The goal has been to investigate if AcouSort’s technology for blood-plasma separation is suitable for combination